Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks

[1]  A. Abernethy,et al.  Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  I. Jatoi,et al.  Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study. , 2016, Cancer epidemiology.

[3]  M. Silverstein,et al.  Oncoplastic breast reconstruction: Patient selection and surgical techniques , 2016, Journal of surgical oncology.

[4]  C. Steiner,et al.  Trends in Bilateral and Unilateral Mastectomies in Hospital Inpatient and Ambulatory Settings, 2005–2013 , 2016 .

[5]  J. Raemaekers,et al.  Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. , 2015, The New England journal of medicine.

[6]  D. Berry,et al.  Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance). , 2015, Annals of surgery.

[7]  L. Pusztai,et al.  Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. , 2015, Journal of the American College of Surgeons.

[8]  Amanda K Silva,et al.  The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis , 2015, Annals of Surgical Oncology.

[9]  L. Hartmann,et al.  Impact of Reconstruction and Reoperation on Long-Term Patient-Reported Satisfaction After Contralateral Prophylactic Mastectomy , 2015, Annals of Surgical Oncology.

[10]  M. Silverstein,et al.  Extreme Oncoplasty: Breast Conservation for Patients Who Need Mastectomy , 2015, The breast journal.

[11]  G. Colditz,et al.  Contralateral Prophylactic Mastectomy After Unilateral Breast Cancer: A Systematic Review and Meta-analysis , 2014, Annals of surgery.

[12]  I. Jatoi,et al.  Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias , 2014, Breast Cancer Research and Treatment.

[13]  David D. Smith,et al.  Survival Analysis of Contralateral Prophylactic Mastectomy: A Question of Selection Bias , 2014, Annals of Surgical Oncology.

[14]  R. Tollenaar,et al.  Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis , 2014, International journal of cancer.

[15]  D. Winchester,et al.  Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. , 2014, Journal of the American College of Surgeons.

[16]  A Hollestelle,et al.  Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy , 2014, British Journal of Cancer.

[17]  D. Winchester,et al.  Impact of Bilateral Versus Unilateral Mastectomy on Short Term Outcomes and Adjuvant Therapy, 2003–2010: A Report from the National Cancer Data Base , 2014, Annals of Surgical Oncology.

[18]  W. Foulkes,et al.  Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis , 2014, BMJ : British Medical Journal.

[19]  Karen R. Sepucha,et al.  Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer , 2013, Annals of Internal Medicine.

[20]  D. Winchester,et al.  Operative Risks Associated with Contralateral Prophylactic Mastectomy: A Single Institution Experience , 2013, Annals of Surgical Oncology.

[21]  I. Buchan,et al.  Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer , 2013, Breast Cancer Research and Treatment.

[22]  M. Morrow,et al.  Long-Term Patient-Reported Satisfaction after Contralateral Prophylactic Mastectomy and Implant Reconstruction , 2013, Annals of Surgical Oncology.

[23]  Jennifer D. Brooks,et al.  Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Cross,et al.  CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  I. Bedrosian,et al.  Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status , 2012, Cancer.

[26]  T. Lister,et al.  Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Sacks,et al.  Reconstructive Outcomes in Patients Undergoing Contralateral Prophylactic Mastectomy , 2011, Plastic and reconstructive surgery.

[28]  L. Hartmann,et al.  Contralateral Prophylactic Mastectomy: Long-Term Consistency of Satisfaction and Adverse Effects and the Significance of Informed Decision-Making, Quality of Life, and Personality Traits , 2011, Annals of Surgical Oncology.

[29]  R Peto,et al.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[30]  E. Elkin,et al.  Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Rosenberg,et al.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  T. Sellers,et al.  Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer , 2010, Annals of Surgical Oncology.

[33]  A. Stewart,et al.  Trends in Contralateral Prophylactic Mastectomy for Unilateral Cancer: A Report From the National Cancer Data Base, 1998–2007 , 2010, Annals of Surgical Oncology.

[34]  I. Bedrosian,et al.  Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. , 2010, Journal of the National Cancer Institute.

[35]  L. V. van't Veer,et al.  Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers , 2005, British Journal of Cancer.

[36]  J. Elmore,et al.  Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[38]  Ellen Warner,et al.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  T. Sellers,et al.  Reoperations after prophylactic mastectomy with or without implant reconstruction , 2003, Cancer.

[40]  B. Emami,et al.  Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. , 2003, International journal of radiation oncology, biology, physics.

[41]  T. Sellers,et al.  Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Andersen,et al.  Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. , 2000, American journal of surgery.

[43]  T. Sellers,et al.  Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. , 2000, JAMA.

[44]  S. Edge,et al.  Treatment of early-stage breast cancer. , 1999, Current problems in cancer.

[45]  S. Dobie,et al.  Prophylactic mastectomy for prevention of breast cancer. , 1999, The Journal of family practice.

[46]  J. Donohue,et al.  Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. , 1995, Surgery.

[47]  Stephen E. Jones.  Implications of the NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer , 1991 .

[48]  M. F. Timothy D. Jackson MD,et al.  Increased Postoperative Complications in Bilateral Mastectomy Patients Compared to Unilateral Mastectomy: An Analysis of the NSQIP Database , 2013, Annals of Surgical Oncology.

[49]  Sarah M. Greene,et al.  Positive, Negative, and Disparate—Women’s Differing Long‐Term Psychosocial Experiences of Bilateral or Contralateral Prophylactic Mastectomy , 2008, The breast journal.

[50]  青儀 健二郎,et al.  What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID: 15894097.--早期乳癌に対する化学療法・内分泌療法が乳癌再発・15年生存率に及 , 2006 .